Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CETP | P11597 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PTGIR | P43119 | 1/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15058493 | 0.85 | HPGD (0.47) | HPGDMGLLRIPK1NPC1RAB9A | |
| SCHEMBL15059092 | 0.84 | RIPK1 (0.40) | HPGDRIPK1NPC1RAB9ACETP | |
| SCHEMBL15076071 | 0.81 | CETP (0.41) | HPGDMGLLNPC1RAB9ACETP | |
| SCHEMBL23519098 | 0.80 | PPARG (0.45) | HPGDNPC1RAB9APPARGPPARA | |
| SCHEMBL15545838 | 0.79 | KCNN4 (0.50) | HPGDNPC1RAB9APPARGPPARA | |
| SCHEMBL15058291 | 0.76 | SLC6A4 (0.35) | RIPK1RAB9AALDH1A1POLB | |
| SCHEMBL17875096 | 0.76 | HDAC1 (0.36) | RAB9AALDH1A1 | |
| SCHEMBL15546762 | 0.76 | POLB (0.49) | PPARGPPARAMRGPRX4LMNAPOLB | |
| SCHEMBL15059514 | 0.73 | FFAR1 (0.39) | HPGDRIPK1RAB9AKMT2A | |
| SCHEMBL3373353 | 0.72 | PPARA (0.54) | PPARGPPARAKMT2AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023247976-A1 | DEUTERATED HERBICIDES BASED ON OXAZINONES AND 6-(TRIFLUOROMETHYL)PYRIMIDINE-2,4-DIONES | REDAG CROP PROTECTION LTD (GB) | 2023-12-28 | — | — | WO | disclosed |
| EP-3010895-B1 | PROCESS FOR MANUFACTURING 4-PROPARGYLATED AMINO-BENZOXAZINONES | BASF SE (DE) | 2017-08-09 | — | — | EP | disclosed |
| EP-3184515-A1 | PROCESS FOR MANUFACTURING 1,4-BENZOXAZINONES | BASF SE (DE) | 2017-06-28 | — | — | EP | disclosed |
| US-9518045-B2 | Process for manufacturing benzoxazinones | BASF SE (DE) | 2016-12-13 | — | — | US | disclosed |
| US-9518045-B2 | Process for manufacturing benzoxazinones | BASF SE (DE) | 2016-12-13 | — | — | US | disclosed |
| US-9518045-B2 | Process for manufacturing benzoxazinones | BASF SE (DE) | 2016-12-13 | — | — | US | disclosed |
| EP-2885281-B1 | CARBAMAT-BENZOXAZINONES USEFUL FOR PREPARING TRIAZIN-BENZOXAZINONES | BASF SE (DE) | 2016-12-07 | — | — | EP | disclosed |
| US-9512093-B2 | Process for manufacturing 4-propargylated amino-benzoxazinones | BASF SE (DE) | 2016-12-06 | — | — | US | disclosed |
| EP-2794554-B1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2016-08-17 | — | — | EP | disclosed |
| EP-2794554-B1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2016-08-17 | — | — | EP | disclosed |
| EP-2794554-A1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| EP-2794579-A1 | PROCESS FOR MANUFACTURING 4-SUBSTITUTED AMINO-BENZOXAZINONES | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| EP-2794599-A1 | PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES | BASF SE (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-20140316131-A1 | PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES | BASF SE (DE) | 2014-10-23 | — | — | US | disclosed |
| WO-2014026928-A1 | PROCESS FOR MANUFACTURING BENZOXAZINONES | BASF SE (DE) | 2014-02-20 | — | — | WO | disclosed |
| WO-2014026893-A1 | CARBAMAT-BENZOXAZINONES | BASF SE (DE) | 2014-02-20 | — | — | WO | disclosed |
| WO-2013092850-A1 | PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092856-A1 | PROCESS FOR MANUFACTURING BENZOXAZINONES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092858-A1 | PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
| WO-2013092859-A1 | PROCESS FOR MANUFACTURING 4-SUBSTITUTED AMINO-BENZOXAZINONES | BASF SE (DE) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140316131-A1 | PROCESS FOR MANUFACTURING TRIAZINON-BENZOXAZINONES | CYP2B6, UGT1A6, UGT2B17 | HPGD 732/4885MGLL 4641/4885RIPK1 3876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.